FutureMeds Chief Client Solutions Officer and Global Project Manager joined Parexel’s “Enabling Successful Sites” podcast to explore the practical solutions for overcoming communication challenges and building stronger sponsor-site partnerships.
What if the greatest challenge in clinical trials isn’t about scientific breakthroughs or cutting-edge technology?
In Parexel’s latest “Enabling Successful Sites” podcast episode, host Karen McIntyre, Vice President, Global Site Alliances sat down with Jakub Jedrzejewski, Global Project Manager at Future Meds, Iwona Tongbhoyai, Chief Client Solutions Officer at Future Meds and Heidi Juncher-Benzon, Senior Director Clinical Operations for EMEA East at Parexel reveal that sometimes the biggest hurdle boils down to something far simpler and more pervasive than technology: transparent, proactive communication.
The conversation uncovers the biggest communication challenges facing sites and strategies to resolve them. From confronting hidden communication gaps and managing timelines more openly, to sharing valuable tools that strengthen sponsor-site relationships, this episode delivers insights that are both practical and transformative.
“This initiative commendably improves site-client collaboration through open dialogue, strengthening connections between research stakeholders and addressing hidden challenges,” says Iwona.
Jakub adds, “The conversation felt like sitting down for coffee with trusted partners, where we could openly address the elephant in the room: communication gaps that silently impact every aspect of our trials.”
If you’re looking to enhance communication, transparency, and efficiency in your clinical trial operations, tune in.
Episode 5, Part One: “Improving Communication Between Sites, Sponsors and CROs” is available at Parexel’s website here: https://www.parexel.com/insights/podcast/enabling-successful-sites-episode-5-part-one-strategies-for-improving-communication-between-sites-sponsors-and-cros
Follow us on LinkedIn
Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.
Comentários